Skip to content

Clinical trials

Phase 3 Leukemia trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia Phase: Phase 3 Country / region: Australia Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20021
20031
20061
20073
20091
20102
20123
20144
20151
20161
20172
20191
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Terminated5
Active, not recruiting3
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group9
Daiichi Sankyo3
Novartis Pharmaceuticals3
AbbVie1
Acerta Pharma BV1
Amgen1
Antisoma Research1
Ariad Pharmaceuticals1
AstraZeneca1
Baxalta now part of Shire1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia34
Leukemia, Myeloid, Acute9
Precursor Cell Lymphoblastic Leukemia-Lymphoma8
Leukemia, Lymphocytic, Chronic, B-Cell6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive5
Lymphoma5
Leukemia, Myeloid4
Bone Marrow Diseases3
Burkitt Lymphoma3
Hematologic Diseases3

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.